neobookRx
DrugsLevel 4 LocalisationS3OPDEML

Brinzolamide

Carbonic anhydrase inhibitorAntiglaucoma agent

Indications

Registered South African indications: 

  • Open angle glaucoma
  • Ocular hypertension

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients 
  • Hypersensitivity to sulphonamides 
  • Severe renal impairment
  • Hyperchloraemic acidosis

Cautions

  • Pregnancy
  • Breastfeeding
  • Hepatic impairment
  • Pseudoexfoliative glaucoma
  • Pigmentary glaucoma
  • Closed angle glaucoma
  • Dry eye
  • Conditions where the cornea is compromised
  • Infants
  • Children
  • Concomitant use of contact lenses
  • May impair ability to drive or operate heavy machinery

Adult dosage

Forms avail. in SA and covered in this monograph: opd

Ocular hypertension
Open angle glaucoma

  • Ophthalmic (opd): 1 drop, into affected eye(s), 8-12hrly

If more than one ocular preparation is used, they should be used at least 10mins apart


When substituting for another antiglaucoma medication, discontinue the agent after a one day of full dosing and start brinzolamide the next day

Paediatric dosage

Not established for use in children

Special populations

Adverse reactions

Central Nervous System Disorders

  • Apathy
  • Depression
  • Decreased libido
  • Nightmare
  • Nervousness
  • Insomnia
  • Motor dysfunction
  • Amnesia
  • Dizziness
  • Paraesthesia
  • Headache
  • Memory impairment
  • Somnolence
  • Tremor
  • Hypoaesthesia
  • Ageusia

Cardiovascular Disorders

  • Cardiorespiratory distress
  • Bradycardia
  • Palpitations
  • Angina pectoris
  • Arrhythmia
  • Tachycardia
  • Hypertension
  • Hypotension

Respiratory Disorders

  • Dyspnoea
  • Epistaxis
  • Oropharyngeal pain
  • Pharyngolaryngeal pain
  • Throat irritation
  • Upper airway cough syndrome
  • Rhinorrhoea
  • Sneezing
  • Bronchial hyperreactivity
  • Upper respiratory tract congestion
  • Sinus congestion
  • Nasal congestion
  • Cough
  • Nasal dryness
  • Asthma

Gastrointestinal Disorders

  • Dysgeusia
  • Oesophagitis
  • Diarrhoea
  • Nausea and vomiting
  • Dyspepsia
  • Upper abdominal pain
  • Abdominal discomfort
  • Stomach discomfort
  • Flatulence
  • Frequent bowel movements
  • Gastrointestinal disorder
  • Oral hypoaesthesia
  • Oral paraesthesia
  • Dry mouth

Hepatobiliary Disorders

  • Abnormal liver function test

Genitourinary Disorders

  • Renal pain
  • Pollakiuria
  • Erectile dysfunction

Endocrine and Metabolic Disorders

  • Decreased appetite

Musculoskeletal Disorders

  • Back pain
  • Muscle spasms
  • Myalgia
  • Arthralgia
  • Pain in extremity

Skin and Subcutaneous Tissue Disorders

  • Maculopapular rash
  • Skin tightness
  • Urticaria
  • Alopecia
  • Pruritus
  • Dermatitis
  • Erythema

Immune, Blood and Lymphatic System Disorders

  • Nasopharyngitis
  • Pharyngitis
  • Sinusitis
  • Rhinitis
  • Decreased red blood cell count
  • Increased blood chloride 
  • Hypersensitivity

Sensory Disorders

  • Blurred vision
  • Eye pain
  • Foreign body sensation in eyes
  • Ocular hyperaemia
  • Corneal erosion
  • Keratitis
  • Punctate keratitis
  • Keratopathy
  • Deposits in eye
  • Corneal staining
  • Corneal epithelium disorder
  • Blepharitis
  • Eye pruritus
  • Conjunctivitis
  • Eye swelling
  • Meibomianitis
  • Photophobia
  • Dry eye
  • Allergic conjunctivitis
  • Pterygium
  • Scleral pigmentation
  • Asthenopia
  • Keratoconjunctivitis sicca
  • Subconjunctival cyst
  • Conjunctival hyperaemia
  • Eyelids pruritus
  • Eye discharge
  • Eyelid margin crusting
  • Corneal oedema
  • Diplopia
  • Photopsia
  • Hypoaesthesia eye
  • Periorbital oedema 
  • Increased optic nerve cup/disc ratio
  • Corneal disorder
  • Visual disturbance
  • Madarosis
  • Erythema of eyelid
  • Tinnitus
  • Vertigo

Interactions

  • Oral carbonic anhydrase inhibitors
  • CYP3A4 inhibitors 

Monitoring

None routine

Mechanism of action

Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. The result is a reduction in intraocular pressure.  

Dosage forms

  • Eye drops

Formulation

Eye drops (per ml) 10mg

  • Azoptic (Novartis South Africa) originator

COMBINATION PREPARATIONS

Brinzolamide/ Timolol

Eye drops (per ml) 10mg/5mg

  • Azarga  (Novartis South Africa) originator

References

1. SAMF_12th edition_Page 578 2. https://www.medicines.org.uk/emc/medicine/2808 (03/09/2014_Alcon_Azopt_eye drop) 3. https://drive.google.com/drive/folders/0B27NqM_vidrmY3JkU0VzdzlSTU0 (19/07/2001_Alcon_Azoptic_eye drop_Intekom) 4. https://drive.google.com/drive/folders/0B27NqM_vidrmY3JkU0VzdzlSTU0 (30/09/2011_Alcon_Azoptic_eye drop)

Brands & products

3 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

dropsGeneric· 3 products

from R67.18/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Azoptic 5ml eye suspension10 mg/ml5S3R335.88R67.18R117.61701523001
Azarga 5ml5 mg/ml5S4R339.09R67.82R118.49717260001
Simbrinza2 mg/ml5S3R345.58R69.12R120.283004660001
Trade names (1)
  • Azoptic

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 16256 · updated 5/17/2024